Pharvaris N.V.
PHVS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001830487
In the last 90 days, Pharvaris N.V. insiders filed 0 open-market purchases and 18 sales; 125 institutions reported holding it in 13F filings for Q2 2026, worth $2.23B in total; Viking Global Investors is the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding Pharvaris N.V. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 20 | 21 | +1 |
| Shares | 22.4M | 22.3M | −38.4K (−0.2%) |
| Value | $494.0M | $173.6M | −$320.4M (−64.9%) |
New holders (2)
Institutions that held Pharvaris N.V. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Tower Research Capital LLC (TRC) | 3,460 | $26.0K | 0.00% |
| BlackRock Inc. | 156 | $1.00K | 0.00% |
Sold out (1)
Institutions that held Pharvaris N.V. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| UBS Group AG | 799 | $18.0K |